Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level-Reference-Cited by-同舟云学术

Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level

Published:2021-07 Issue: Volume:201 Page:114129
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Zhang Nan,Gao Ming,Wang Zihan,Zhang Jingxian,Cui Weiqi,Li Jinjin,Zhu Xiaolin,Zhang Hang,Yang Dong-Hua,Xu Xia

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference35 articles.

1. Ginnalin A from Kujin tea (Acer tataricum subsp ginnala) exhibits a colorectal cancer chemoprevention effect via activation of the Nrf2/HO-1 signaling pathway;Bi;Food Funct.,2018

2. Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance;Xu;PLoS One,2013

3. Effect of traditional Chinese medicine components on multidrug resistance in tumors mediated by P-glycoprotein (Review);Xia;Oncol. Lett.,2017

4. Novel strategies to prevent the development of multidrug resistance (MDR) in cancer;Wang;Oncotarget,2017

5. ABC transporters as mediators of drug resistance and contributors to cancer cell biology;Fletcher;Drug Resist. Updates,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Periodate-Induced Cross-linking on Dual Anticancer Drug Release from Poly(2-isopropyl-2-oxazoline)/Tannic Acid-Based Layer-by-Layer Microparticles;ACS Omega;2024-09-11

2. Natural Products and Derivatives Targeting Metabolic Reprogramming in Colorectal Cancer: A Comprehensive Review;Metabolites;2024-09-09

3. Modulation of Multidrug Resistance Transporters by Food Components and Dietary Supplements: Implications for Cancer Therapy Efficacy and Safety;Current Issues in Molecular Biology;2024-09-02

4. Exploration of the intracellular chiral metabolome in pediatric BCP-ALL: a pilot study investigating the metabolic phenotype of IgH locus aberrations;Frontiers in Oncology;2024-08-05

5. Targeting Metabolic–Redox Nexus to Regulate Drug Resistance: From Mechanism to Tumor Therapy;Antioxidants;2024-07-10